Effects of Spironolactone on Cardio- and Cerebrovascular Morbidity and Mortality in Hemodialysis Patients

Clinical trial NCT01687699 · COMPLETED

Trial details

NCT number: NCT01687699
Sponsor: Dialysis Outcomes Heart Failure Aldactone Study Group
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

End-stage Renal Failure

Start date: 2008-04-01
Primary completion: 2008-12-01
Enrollment: 157

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.